Search

Your search keyword '"Cosset, J. M."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Cosset, J. M." Remove constraint Author: "Cosset, J. M." Search Limiters Full Text Remove constraint Search Limiters: Full Text
31 results on '"Cosset, J. M."'

Search Results

Catalog

Books, media, physical & digital resources

11. Hodgkins disease

12. First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

21. A lost pigtail.

22. Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.

23. Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm.

24. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?

25. Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up.

26. Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease.

27. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia.

28. Blood lymphocyte subsets after the first fraction in patients given hyperfractionated total body irradiation for bone marrow transplantation.

29. Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group.

30. Similar effects on murine haemopoietic compartment of low dose rate single dose and high dose rate fractionated total body irradiation. Preliminary results after a unique dose of 750 cGy.

31. Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft.